Developing new treatments to combat bacterial resistance using biopharmaceuticals
Official title: Preclinical Services for Antibacterial Resistance Biopharmaceutical Product Development
Funded at Research Triangle Institute · NIH-10934774 · Data updated 2026-11-12
This study is working on new treatments to help fight infections caused by bacteria that don't respond to regular medicines, using special tools like antibodies and RNA, to make sure patients have better options for getting better.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Research Triangle Institute NIH-funded |
| Lab location | 1 site (Research Triangle Park, United States) |
| Project start | September 8, 2023 |
| Project end | September 7, 2030 |
| Funding year | 2023 |
| Award (this year) | $2,589 |
| NIH project number | 75N93023D00012-0-759302300001-1 |
| Project ID | NIH-10934774 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals suffering from infections that are resistant to standard antibiotic treatments.
✕Less likely to help
Patients with infections that are easily treatable with existing antibiotics may not benefit from this research.
What this research studies
This research focuses on the preclinical development of innovative biopharmaceutical products aimed at addressing bacterial drug resistance. It involves creating and evaluating various biological materials, including monoclonal antibodies and small interfering RNA (siRNA) vectors, to enhance treatment options for infectious diseases. The program provides comprehensive services such as product development planning, assay development, and regulatory support to ensure effective translation of these therapies from the lab to clinical settings.
Why it matters
Potential benefit: If successful, this research could lead to new and effective treatments for infections caused by antibiotic-resistant bacteria.
How similar studies have gone: Other research in the field of biopharmaceuticals and antibiotic resistance has shown promising results, indicating that this approach has potential for success.
Where this research is happening
-
Research Triangle Institute
Research Triangle Park, United States Active
Related research
Other NIH-funded projects on the same topics.
-
Improving engagement and retention in the All of Us Research Program for children and youth.
This study is all about making online experiences better for kids and teens involved in the All of Us Research Program by listening to their ideas and working together to create new tools that fit their needs.
-
Improving population health and preventing disease across the life course
This study is looking at how different factors influence pregnancy and child development to help improve health for families, especially for couples trying to conceive, pregnant women, and young children.
-
Improving data resources for sickle cell disease management
This study is working to make it easier for people with sickle cell disease to share and access important health information, so they can have a better experience and help researchers find new ways to improve their care.
-
Improving colorectal cancer screening and follow-up care.
This study is working to help more people get screened for colorectal cancer and receive the follow-up care they need, especially those who haven't been screened much before, so that everyone can have better access to important health checks and improve their overall health.
-
BioData Catalyst Data Management Core Program
A data-management program that makes NHLBI-funded heart, lung, blood, and sleep research data easier to use and share, with strong data security and AI-powered tools.
-
Stillbirth Data Hub: Coordinating Center for Big-Data and AI in Stillbirth Research
A national data hub is being built to coordinate data, biorepository, and analytics for stillbirth research using advanced AI and machine learning.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.